Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-09-26

Clinical Trial Update: Photoscreening for Retinoblastoma [NA]

View source ↗

Summary

A clinical trial investigating photoscreening for retinoblastoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Phoenix Children's Hospital | Conditions: Retinoblastoma | NA | Status: WITHDRAWN